[go: up one dir, main page]

WO2009038157A1 - ２，３－ジヒドロ－イミノイソインドール誘導体 - Google Patents

２，３－ジヒドロ－イミノイソインドール誘導体 Download PDF

Info

Publication number
WO2009038157A1
WO2009038157A1 PCT/JP2008/066944 JP2008066944W WO2009038157A1 WO 2009038157 A1 WO2009038157 A1 WO 2009038157A1 JP 2008066944 W JP2008066944 W JP 2008066944W WO 2009038157 A1 WO2009038157 A1 WO 2009038157A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
salt
optionally substituted
inhibitory activity
dihydroiminoisoindole
Prior art date
Application number
PCT/JP2008/066944
Other languages
English (en)
French (fr)
Inventor
Richard Clark
Atsushi Takemura
Nobuhisa Watanabe
Osamu Asano
Tadashi Nagakura
Kimiyo Tabata
Original Assignee
Eisai R & D Management Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R & D Management Co., Ltd. filed Critical Eisai R & D Management Co., Ltd.
Priority to EP08832347A priority Critical patent/EP2202231A4/en
Priority to JP2009533188A priority patent/JPWO2009038157A1/ja
Publication of WO2009038157A1 publication Critical patent/WO2009038157A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

　一般式（１） ［式中、Ｒ１は、水素原子を意味する。Ｒ２は、置換基を有していてもよいフェニル基等を意味する。Ｒ３は、置換基を有していてもよいＣ６－１０アリール基等を意味する。］で表される化合物またはその塩は、セリンプロテアーゼ阻害活性を有しており、特に血液凝固第ＶＩＩａ因子に対する阻害活性に優れる。この化合物またはその塩は、血栓形成に起因する疾患の治療剤および／または予防剤として有用である。
PCT/JP2008/066944 2007-09-21 2008-09-19 ２，３－ジヒドロ－イミノイソインドール誘導体 WO2009038157A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP08832347A EP2202231A4 (en) 2007-09-21 2008-09-19 2,3-DIHYDROIMINOISOINDOLE DERIVATIVE
JP2009533188A JPWO2009038157A1 (ja) 2007-09-21 2008-09-19 ２，３−ジヒドロ−イミノイソインドール誘導体

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2007245988 2007-09-21
JP2007-245988 2007-09-21
US97505507P 2007-09-25 2007-09-25
US60/975,055 2007-09-25

Publications (1)

Publication Number Publication Date
WO2009038157A1 true WO2009038157A1 (ja) 2009-03-26

Family

ID=40467966

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/066944 WO2009038157A1 (ja) 2007-09-21 2008-09-19 ２，３－ジヒドロ－イミノイソインドール誘導体

Country Status (4)

Country Link
US (2) US7807690B2 (ja)
EP (1) EP2202231A4 (ja)
JP (1) JPWO2009038157A1 (ja)
WO (1) WO2009038157A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1810965A4 (en) * 2004-10-13 2009-10-28 Eisai R&D Man Co Ltd HYDRAZIDE DERIVATIVES
ITMI20051085A1 (it) * 2005-06-10 2006-12-11 Acs Dobfar Spa Metodo di purificazione del cefotetan
KR101362024B1 (ko) * 2006-03-24 2014-02-11 에자이 알앤드디 매니지먼트 가부시키가이샤 트리아졸론 유도체
US7807690B2 (en) 2007-09-21 2010-10-05 Eisai R&D Management Co., Ltd. 2,3-dihydro-iminoisoindole derivatives
TW201206905A (en) 2010-05-20 2012-02-16 Eisai R & Amp D Man Co Ltd Prodrug of triazolone compound

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002509924A (ja) * 1998-03-27 2002-04-02 デュポン ファーマシューティカルズ カンパニー 第Ｘａ因子阻害剤としてのジ置換ピラゾリン類およびトリアゾリン類
WO2002085855A1 (fr) * 2001-04-19 2002-10-31 Eisai Co., Ltd. Derives de 2-iminopyrrolidine
JP2002543176A (ja) * 1999-05-04 2002-12-17 サノフィ−サンテラボ ６−［［（アリールおよびヘテロアリール）オキシ］メチル］ナフタレン−２−カルボキシイミドアミド誘導体、それらの製造法およびそれらの治療的適用
WO2007111212A1 (ja) * 2006-03-24 2007-10-04 Eisai R & D Management Co., Ltd. トリアゾロン誘導体

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0019586A1 (de) 1979-05-11 1980-11-26 Ciba-Geigy Ag Neue antithrombotische Kombinationspräparate
SU1512055A1 (ru) 1987-12-04 1992-07-23 Пермский фармацевтический институт Дигидрохлорид гидразида N-ацетил-N-аллилантраниловой кислоты, про вл ющий антиагрегатную активность по отношению к тромбоцитам плазмы крови
CA2301559A1 (en) 1997-08-27 1999-03-04 Norihiko Kikuchi 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both
AU2300699A (en) 1998-02-17 1999-08-30 Ono Pharmaceutical Co. Ltd. Amidino derivatives and drugs containing the same as the active ingredient
HUP0104421A3 (en) 1998-12-14 2003-05-28 Hoffmann La Roche Phenylglycine derivatives
ATE307111T1 (de) 1999-01-13 2005-11-15 Genentech Inc Serinprotease-inhibitoren
FR2791683A1 (fr) 1999-03-30 2000-10-06 Synthelabo Derives de n-sulfonyl-dipeptides, leur preparation et leur application en therapeutique
US6548694B2 (en) 2000-05-23 2003-04-15 Hoffman-La Roche Inc. N-(4-carbamimidoyl-phenyl)-glycine derivatives
EP1162194A1 (en) 2000-06-06 2001-12-12 Aventis Pharma Deutschland GmbH Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
EP1312602A1 (en) 2001-11-15 2003-05-21 Eisai Co., Ltd. Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them
JP4209659B2 (ja) 2001-11-15 2009-01-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 アミジノ誘導体並びにそれを用いた抗血液凝固剤および血栓症治療剤
AU2003284001A1 (en) 2002-10-07 2004-05-04 Bristol-Myers Squibb Company Triazolone and triazolethione derivatives
EP1479679A1 (en) 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Triazole-derivatives as factor Xa inhibitors
EP1810965A4 (en) 2004-10-13 2009-10-28 Eisai R&D Man Co Ltd HYDRAZIDE DERIVATIVES
ES2310861T3 (es) 2004-12-08 2009-01-16 Bristol-Myers Squibb Company Compuestos heterociclicos como inhibidores del factor viia.
US7807690B2 (en) 2007-09-21 2010-10-05 Eisai R&D Management Co., Ltd. 2,3-dihydro-iminoisoindole derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002509924A (ja) * 1998-03-27 2002-04-02 デュポン ファーマシューティカルズ カンパニー 第Ｘａ因子阻害剤としてのジ置換ピラゾリン類およびトリアゾリン類
JP2002543176A (ja) * 1999-05-04 2002-12-17 サノフィ−サンテラボ ６−［［（アリールおよびヘテロアリール）オキシ］メチル］ナフタレン−２−カルボキシイミドアミド誘導体、それらの製造法およびそれらの治療的適用
WO2002085855A1 (fr) * 2001-04-19 2002-10-31 Eisai Co., Ltd. Derives de 2-iminopyrrolidine
WO2007111212A1 (ja) * 2006-03-24 2007-10-04 Eisai R & D Management Co., Ltd. トリアゾロン誘導体

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2202231A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof

Also Published As

Publication number Publication date
US7807690B2 (en) 2010-10-05
JPWO2009038157A1 (ja) 2011-01-06
US20090270433A1 (en) 2009-10-29
EP2202231A1 (en) 2010-06-30
EP2202231A4 (en) 2011-09-28
US20100184981A1 (en) 2010-07-22

Similar Documents

Publication Publication Date Title
MX2009010491A (es) Derivado heterociclico de 5 miembros y su uso para propositos medicos.
MX2009010966A (es) Derivado de (aza)indol y su uso para propositos medicos.
WO2008075068A3 (en) Acylaminopyrazoles as fgfr inhibitors
NO20080865L (no) Spirokromanonderivater som acetyl-koenzym-A-karboksylase(ACC)inhibitorer
WO2009038157A1 (ja) ２，３－ジヒドロ－イミノイソインドール誘導体
NO20072605L (no) Nytt antranilinsyrederivat eller et salt derav
WO2006113942A3 (en) Method of inhibiting cathepsin activity
WO2008062905A3 (en) Heteromonocyclic compound and use thereof
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
ATE540928T1 (de) Isochinolinverbindungen und ihre medizinische verwendung
EP1568699A4 (en) 1,3-DIHYDROIMIDAZOLE CONNECTION WITH CONDENSED RING
WO2007025307A3 (en) Inhibitors of serine proteases
IL179728A0 (en) Indoles useful in the treatment of inflammation
MY146537A (en) Triazolone derivative
TW200745062A (en) Macrocyclic factor VIIA inhibitors useful as anticoagulants
NO20064344L (no) Caspaseinhibitorer og anvendelser derav
WO2008079873A3 (en) Thiazolyl compounds useful as kinase inhibitors
WO2006047528A3 (en) Pyrazolobenzamides and derivatives as factor xa inhibitors
MY139461A (en) Condensed furan compounds
WO2006041831A3 (en) Cyclic β-amino acid derivatives as factor xa inhibitors
WO2009020137A1 (ja) アミノピラゾールアミド誘導体
WO2008000421A3 (en) Thiazolyl urea derivatives as phosphatidylinositol 3-kinase inhibitors
WO2008136378A1 (ja) 新規なスルホンアミド誘導体またはその塩
WO2005005415A8 (en) Indoles useful in the treatment of inflammation
WO2009019815A1 (ja) 新規γセクレターゼ阻害剤

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08832347

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009533188

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008832347

Country of ref document: EP